Share:
Peer-Reviewed Publication
Nat Biotechnol2026June 25, 2026Journal Article

Toward mechanistic virtual immune cells.

Christian M Beusch1,2,3,4,5, Brice Edelman6, Chase A Hubbard6, Jovan S Brockett1,2,3,4, Jeffrey Skolnick6, David E Gordon7,8,9,10
1Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
2Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
3Winship Cancer Institute, Emory University, Atlanta, GA, USA.
4Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, USA.
5Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
6Center for the Study of Systems Biology, Georgia Institute of Technology, Atlanta, GA, USA.
7Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. david.ezra.gordon@emory.edu.
8Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. david.ezra.gordon@emory.edu.
9Winship Cancer Institute, Emory University, Atlanta, GA, USA. david.ezra.gordon@emory.edu.
10Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, USA. david.ezra.gordon@emory.edu.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.